天然产物研究与开发 ›› 2024, Vol. 36 ›› Issue (增刊2): 94-106.

• 数据研究 • 上一篇    下一篇

基于网络药理学及分子对接探讨苏木治疗糖尿病周围神经病变的作用机制

刘影哲1,吕   蓉2,夏兆晨2,3,王   岩1,王   贺1,兰冬雪2,李喜伟1,张莹琪2,周亚滨1*   

  1. 1黑龙江中医药大学附属第一医院;2黑龙江中医药大学,哈尔滨 150040;3昆山市中医医院,昆山 215300
  • 出版日期:2024-12-09 发布日期:2024-12-09
  • 基金资助:
    黑龙江省中医药管理局中医药科研课题(ZHY2022-156);黑龙江省博士后科研启动金(LBH-Q13168)

Mechanism of Sappan Lignum in the treatment of diabetic peripheral neuropathy based on network pharmacology and molecular docking

LIU Ying-zhe1,LYU Rong2,XIA Zhao-chen2,3,WANG Yan1,WANG He1,LAN Dong-xue2,LI Xi-wei1,ZHANG Ying-qi2,ZHOU Ya-bin1*   

  1. 1First Affiliated Hospital of Heilongjiang University of Chinese Medicine;2Heilongjiang University of Chinese Medicine,Harbin 150040,China;3Kunshan Hospital of Traditional Chinese Medicine,Kunshan 215300,China
  • Online:2024-12-09 Published:2024-12-09

摘要:

采用网络药理学、分子对接和实验验证的方法探究苏木治疗周围神经病变(diabetic peripheral neuropathy,DPN)的作用机制。通过化学专业数据库、ETCM数据库及文献检索进行苏木成分查询,通过SwissADME平台筛选出苏木的活性成分,再利用PharmMapper数据库预测出潜在作用靶标,同时从GeneCards、DrugBank、OMIM数据库筛选与DPN疾病相关的靶点,取两者交集靶点;用STRING 11.5获得蛋白互作关系,并通过Cytoscape 3.8.2软件构建出成分-靶点蛋白相互作用网络;再通过Metascape数据库进行GO、KEGG富集分析及Autodock联合Pymol进行分子对接,同时对苏木提取物抗DPN炎症作用及氧化作用进行实验验证。最后共筛选出苏木共有93个活性成分,治疗DPN关键靶点109个,其中鼠李素、巴西苏木素、氧化巴西苏木素、苏木查尔酮、紫铆花素、槲皮素等成分具有改善周围神经病变的作用,其可能是通过雌激素受体1(estrogen receptor alpha,ESR1)、胰岛素样生长因子1(insulin-like growth factor-1,IGF1)、半胱氨酸蛋白酶3(Caspase 3,CASP3)、过氧化物酶体增殖激活受体γ(peroxisome proliferator activator receptor gamma,PPARG)、基质金属蛋白酶-2(matrixmetalloproteinase-2,MMP-2)、基质金属蛋白酶-9(matrixmetalloproteinase-9,MMP-9)、表皮生长因子受体(epidermal growth factor receptor,EGFR)、蛋白激酶B1(rac-alpha serine/threonine-protein kinase,AKT1)、血清白蛋白(albumin,ALB)、原癌基因酪氨酸蛋白激酶Src(proto-oncogene tyrosine-protein kinase src,SRC)等靶点介导PI3K-Akt信号通路、MAPK信号通路、AGE-RAGE信号通路、HIF-1信号通路、RAS信号通路等发挥治疗作用。分子对接验证发现活性成分与AKT1、CASP3、MMP-9有较好的对接活性。实验发现苏木提取物可以降低血清肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素-6(interleukin-6,IL-6)、单核细胞趋化因子1(monocyte chemoattractant protein-1,MCP-1)的含量,提升血清超氧化物歧化酶(superoxide dismutase,SOD)的含量。本次研究发现苏木可通过多成分、多靶点、多途径起到干预治疗DPN的作用,为苏木治疗DPN的基础和临床研究提供新方向。

关键词: 网络药理学, 分子对接, 苏木, 糖尿病周围神经病变, 信号通路

Abstract:

In this study,network pharmacology,molecular docking and experimental verification were used to explore the mechanism of Sappan Lignum in the treatment of diabetic peripheral neuropathy (DPN).The chemical professional database,ETCM database and literature were used to query the components of Sappan Lignum,the active components of Sappan Lignum were screened by SwissADME platform,and the potential targets were predicted by PharmMapper database.At the same time,the targets related to DPN disease were screened from GeneCards,DrugBank and OMIM databases,and the intersection targets were selected.The protein interaction relationship was obtained by STRING11.5,and the component-target protein interaction network was constructed by Cytoscape 3.8.2 software.Then GO and KEGG enrichment analysis was carried out through Metascape database,and molecular docking was carried out by Autodock combined with Pymol,At the same time,the anti-DPN inflammation and oxidation effects of Sappan Lignum extract were experimentally verified.Finally,a total of 93 active components of Sappan Lignum were screened out,and 109 key targets for treating DPN were identified.Among them,rhamnetin,brazilin,brazilein, sappanchalcone,butein, quercetin and other components have the effect of improving peripheral neuropathy,which may be through estrogen receptor alpha(ESR1),insulin-like growth factor-1(IGF1),Caspase 3(CASP3),peroxisome proliferator activator receptor gamma(PPARG),matrix metalloproteinase-2(MMP-2),matrix metalloproteinase-9 (MMP-9),epidermal growth factor receptor(EGFR),RAC-alpha serine/threonine-protein kinase(Akt1),albumin(ALB),proto-oncogene tyrosine-protein kinase src(SRC) and other targets mediate PI3K-Akt signaling pathway,MAPK signaling pathway,AGE-RAGE signaling pathway and HIF.Molecular docking verification showed that the active components had good docking activity with AKT1,CASP3 and MMP-9.It was found that Sappan Lignum extract could reduce the contents of serum tumor necrosis factor-α(TNF-α),interleukin-6(IL-6) and monocyte chemoattractant protein-1(MCP-1),and increase the content of serum SOD.This study found that Sappan Lignum played an intervention role in the treatment of DPN through multi-components,multi-targets and multi-pathways,which provides a new direction for the basic and clinical research of Sappan Lignum in the treatment of DPN.

Key words: network pharmacology, molecular docking, Sappan Lignum, diabetic peripheral neuropathy, signaling pathway

中图分类号:  R285